(Q34361636)

English

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

antimycobacterial

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

object named as

Helen A Fletcher

7

0 references

object named as

Sheila M Keating

4

0 references

Adrian V. S. Hill

8

object named as

Adrian V S Hill

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

object named as

Helen McShane

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

object named as

Ansar A Pathan

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Clare R Sander

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

24 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1240-1244

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

How can immunology contribute to the control of tuberculosis?

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Correlates of protective immunity to Mycobacterium tuberculosis in humans

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG.

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

21 January 2018

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1128

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

release_m2ddk4rydnholgxtholbnhilm4

1 reference

https://api.fatcat.wiki/v0/release/m2ddk4rydnholgxtholbnhilm4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34361636&oldid=2196548385"